VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,452,000 | -85.6% | 100,000 | -75.6% | 0.06% | -84.7% |
| Q3 2016 | $10,058,000 | +42.7% | 409,661 | +17.0% | 0.38% | +57.8% |
| Q2 2016 | $7,049,000 | -90.8% | 350,000 | -53.6% | 0.24% | -90.9% |
| Q4 2015 | $76,594,000 | +154.3% | 753,500 | +455.7% | 2.67% | +155.4% |
| Q2 2015 | $30,124,000 | -74.7% | 135,600 | -77.3% | 1.04% | -73.7% |
| Q1 2015 | $118,834,000 | +301.3% | 598,300 | +189.2% | 3.98% | +328.8% |
| Q4 2014 | $29,609,000 | +2.6% | 206,900 | -6.0% | 0.93% | 0.0% |
| Q3 2014 | $28,864,000 | – | 220,000 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |